Driving Computational Pathology in Oncology Drug Development
Time: 2:50 pm
day: Day One
Details:
• Computational Pathology provides greater analytical precision and potentially greater clinical accuracy – enabling identification of best patient populations for clinical response to oncology therapies
• Quantitative Continuous Scoring (QCS) was developed to both quantify target expression in individual tumor's cells and to quantify spatial heterogeneity of expression
• Discussing how to leverage Computational Pathology approaches in oncology drug development
